TERCONAZOLE
Substance profile for UNII 0KJ2VE664U, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 480953Substance Identity#
- UNII
- 0KJ2VE664U
- Preferred term
- TERCONAZOLE
- Registry number
- 67915-31-5
- EC number
- 267-751-6
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C26H31Cl2N5O3
Structure render from PubChem CID 480953Chemical And Database Identifiers#
- SMILES
- CC(C)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=NC=N4)(O3)C5=CC=C(Cl)C=C5Cl)C=C2
- RxCUI
- 37806
- PubChem
- 480953
- NCIt
- C29493
- INN ID
- 4815
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| TERCONAZOLE | ACTIVE MOIETY | 0KJ2VE664U | TERCONAZOLE VAGINAL CREAM 0.4% 7-Day Regimen TERCONAZOLE VAGINAL CREAM 0.4% 3-Day Regimen | 3 | |
| TERCONAZOLE | ACTIVE INGREDIENT | 0KJ2VE664U | TERCONAZOLE VAGINAL CREAM 0.4% 7-Day Regimen TERCONAZOLE VAGINAL CREAM 0.4% 3-Day Regimen | 3 | |
| TERCONAZOLE | ACTIVE MOIETY | 0KJ2VE664U | TERCONAZOLE VAGINAL CREAM 0.4% 7-Day Regimen TERCONAZOLE VAGINAL CREAM 0.8% 3-Day Regimen | 1 | |
| TERCONAZOLE | ACTIVE INGREDIENT | 0KJ2VE664U | TERCONAZOLE VAGINAL CREAM 0.4% 7-Day Regimen TERCONAZOLE VAGINAL CREAM 0.8% 3-Day Regimen | 1 | |
| TERCONAZOLE | ACTIVE INGREDIENT | 0KJ2VE664U | TERCONAZOLE VAGINAL CREAM 0.8% 3-Day Regimen | 1 | |
| TERCONAZOLE | ACTIVE MOIETY | 0KJ2VE664U | TERCONAZOLE VAGINAL CREAM 0.8% 3-Day Regimen | 1 | |
| Terconazole | ACTIVE INGREDIENT | 0KJ2VE664U | TERCONAZOLE VAGINAL CREAM 0.4% | 1 | |
| Terconazole | ACTIVE MOIETY | 0KJ2VE664U | TERCONAZOLE VAGINAL CREAM 0.4% | 1 | |
| TERCONAZOLE | ACTIVE INGREDIENT | 0KJ2VE664U | ab315b6d-e6d1-462d-a777-411986126941 | 1 | |
| TERCONAZOLE | ACTIVE MOIETY | 0KJ2VE664U | ab315b6d-e6d1-462d-a777-411986126941 | 1 | |
| TERCONAZOLE | ACTIVE MOIETY | 0KJ2VE664U | TERCONAZOLE VAGINAL CREAM 0.4% | 1 | |
| TERCONAZOLE | ACTIVE INGREDIENT | 0KJ2VE664U | TERCONAZOLE VAGINAL CREAM 0.4% | 1 | |
| TERCONAZOLE | ACTIVE MOIETY | 0KJ2VE664U | TERAZOL 7 (TERCONAZOLE) CREAM TERAZOL 3 (TERCONAZOLE) CREAM TERAZOL 3 (TERCONAZOLE) SUPPOSITORY [ORTHO-MCNEIL-JANSSEN PHARMACEUTICAL] | 9 | |
| TERCONAZOLE | ACTIVE INGREDIENT | 0KJ2VE664U | TERAZOL 7 (TERCONAZOLE) CREAM TERAZOL 3 (TERCONAZOLE) CREAM TERAZOL 3 (TERCONAZOLE) SUPPOSITORY [ORTHO-MCNEIL-JANSSEN PHARMACEUTICAL] | 9 | |
| TERCONAZOLE | ACTIVE INGREDIENT | 0KJ2VE664U | TERCONAZOLE CREAM [ACTAVIS PHARMA, INC] | 6 | |
| TERCONAZOLE | ACTIVE MOIETY | 0KJ2VE664U | TERCONAZOLE CREAM [ACTAVIS PHARMA, INC] | 6 | |
| TERCONAZOLE | ACTIVE MOIETY | 0KJ2VE664U | ZAZOLE (TERCONAZOLE) CREAM [PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 5 | |
| TERCONAZOLE | ACTIVE INGREDIENT | 0KJ2VE664U | ZAZOLE (TERCONAZOLE) CREAM [PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 5 | |
| TERCONAZOLE | ACTIVE MOIETY | 0KJ2VE664U | TERAZOL 7 (TERCONAZOLE) CREAM TERAZOL 3 (TERCONAZOLE) CREAM TERAZOL 3 (TERCONAZOLE) SUPPOSITORY [JANSSEN PHARMACEUTICALS, INC.] | 4 | |
| TERCONAZOLE | ACTIVE INGREDIENT | 0KJ2VE664U | TERAZOL 7 (TERCONAZOLE) CREAM TERAZOL 3 (TERCONAZOLE) CREAM TERAZOL 3 (TERCONAZOLE) SUPPOSITORY [JANSSEN PHARMACEUTICALS, INC.] | 4 | |
| TERCONAZOLE | ACTIVE MOIETY | 0KJ2VE664U | TERCONAZOLE CREAM [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 4 | |
| TERCONAZOLE | ACTIVE INGREDIENT | 0KJ2VE664U | TERCONAZOLE CREAM [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 4 | |
| Terconazole | ACTIVE MOIETY | 0KJ2VE664U | TERCONAZOLE CREAM [TARO PHARMACEUTICALS U.S.A., INC.] | 4 | |
| Terconazole | ACTIVE INGREDIENT | 0KJ2VE664U | TERCONAZOLE CREAM [TARO PHARMACEUTICALS U.S.A., INC.] | 4 | |
| Terconazole | ACTIVE INGREDIENT | 0KJ2VE664U | TERCONAZOLE CREAM [TARO PHARMACEUTICALS U.S.A., INC.] | 4 | |
| Terconazole | ACTIVE MOIETY | 0KJ2VE664U | TERCONAZOLE CREAM [TARO PHARMACEUTICALS U.S.A., INC.] | 4 | |
| TERCONAZOLE | ACTIVE MOIETY | 0KJ2VE664U | TERCONAZOLE SUPPOSITORY [PERRIGO NEW YORK INC] | 3 | |
| TERCONAZOLE | ACTIVE INGREDIENT | 0KJ2VE664U | TERCONAZOLE SUPPOSITORY [PERRIGO NEW YORK INC] | 3 | |
| Terconazole | ACTIVE INGREDIENT | 0KJ2VE664U | TERCONAZOLE SUPPOSITORY [TARO PHARMACEUTICALS U.S.A., INC.] | 3 | |
| Terconazole | ACTIVE MOIETY | 0KJ2VE664U | TERCONAZOLE SUPPOSITORY [TARO PHARMACEUTICALS U.S.A., INC.] | 3 | |
| terconazole | ACTIVE MOIETY | 0KJ2VE664U | ZAZOLE (TERCONAZOLE) CREAM [ PHARMADERM, A DIVISION OF NYCOMED US INC.] | 3 | |
| terconazole | ACTIVE INGREDIENT | 0KJ2VE664U | ZAZOLE (TERCONAZOLE) CREAM [ PHARMADERM, A DIVISION OF NYCOMED US INC.] | 3 | |
| terconazole | ACTIVE INGREDIENT | 0KJ2VE664U | TERCONAZOLE (TERCONAZOLE) CREAM [E. FOUGERA & CO. A DIVISION OF NYCOMED US INC.] | 2 | |
| terconazole | ACTIVE MOIETY | 0KJ2VE664U | TERCONAZOLE (TERCONAZOLE) CREAM [E. FOUGERA & CO. A DIVISION OF NYCOMED US INC.] | 2 | |
| TERCONAZOLE | ACTIVE INGREDIENT | 0KJ2VE664U | ZAZOLE (TERCONAZOLE) SUPPOSITORY [PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 2 | |
| TERCONAZOLE | ACTIVE MOIETY | 0KJ2VE664U | ZAZOLE (TERCONAZOLE) SUPPOSITORY [PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 2 | |
| TERCONAZOLE | ACTIVE INGREDIENT | 0KJ2VE664U | TERAZOL 3 (TERCONAZOLE) CREAM [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| TERCONAZOLE | ACTIVE MOIETY | 0KJ2VE664U | TERAZOL 3 (TERCONAZOLE) CREAM [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| Terconazole | ACTIVE MOIETY | 0KJ2VE664U | TERCONAZOLE SUPPOSITORY [G & W LABORATORIES, INC.] | 1 | |
| Terconazole | ACTIVE INGREDIENT | 0KJ2VE664U | TERCONAZOLE SUPPOSITORY [G & W LABORATORIES, INC.] | 1 | |